Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Kura Oncology (KURA) Leases (2023 - 2025)

Kura Oncology (KURA) has disclosed Leases for 3 consecutive years, with $7.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Leases rose 25.83% to $7.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.3 million, a 25.83% increase, with the full-year FY2025 number at $7.3 million, up 25.83% from a year prior.
  • Leases was $7.3 million for Q4 2025 at Kura Oncology, down from $7.5 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $8.1 million in Q1 2025 to a low of $2.9 million in Q2 2023.
  • A 3-year average of $6.4 million and a median of $6.8 million in 2023 define the central range for Leases.
  • Biggest YoY gain for Leases was 118.21% in 2024; the steepest drop was 17.02% in 2024.
  • Kura Oncology's Leases stood at $7.0 million in 2023, then dropped by 17.02% to $5.8 million in 2024, then increased by 25.83% to $7.3 million in 2025.
  • Per Business Quant, the three most recent readings for KURA's Leases are $7.3 million (Q4 2025), $7.5 million (Q3 2025), and $7.9 million (Q2 2025).